These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32553721)

  • 21. Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity.
    Padoan A; Zuin S; Cosma C; Basso D; Plebani M; Bonfante F
    Clin Chim Acta; 2020 Nov; 510():654-655. PubMed ID: 32818490
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys® Anti-SARS-CoV-2 assay.
    Tang NY; Yeo KJ; van Wijk XMR
    Clin Chim Acta; 2020 Oct; 509():293-294. PubMed ID: 32598879
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation.
    Kavsak PA; de Wit K; Worster A
    Clin Chem Lab Med; 2020 Jun; 58(7):1142-1143. PubMed ID: 32301748
    [No Abstract]   [Full Text] [Related]  

  • 25. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 26. What to Expect from Antibody Assays of SARS-CoV-2?
    Yi X; Cao J
    J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
    [No Abstract]   [Full Text] [Related]  

  • 27. The Promise and Peril of Antibody Testing for COVID-19.
    Abbasi J
    JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-Specific Laboratory Tests in Patients with COVID-19.
    Borai A
    Ann Clin Lab Sci; 2020 Jul; 50(4):528-535. PubMed ID: 32826251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients.
    Khartabil TA; Russcher H; van der Ven A; de Rijke YB
    Crit Rev Clin Lab Sci; 2020 Sep; 57(6):415-431. PubMed ID: 32568604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges.
    Charra B; Ellouadghiri A; Magramane A; Kebbou T; Damaan K; Maghfour A; Seddiki K; Ezzouine H
    Pan Afr Med J; 2020; 36():286. PubMed ID: 33117480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
    Lippi G; Plebani M
    Clin Chim Acta; 2020 Jun; 505():190-191. PubMed ID: 32145275
    [No Abstract]   [Full Text] [Related]  

  • 32. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Uncomplicated Delivery in a Patient with Covid-19 in the United States.
    Iqbal SN; Overcash R; Mokhtari N; Saeed H; Gold S; Auguste T; Mirza MU; Ruiz ME; Chahine JJ; Waga M; Wortmann G
    N Engl J Med; 2020 Apr; 382(16):e34. PubMed ID: 32237670
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
    Kauv J; Lê MP; Veyrier M; Le Hingrat Q; Visseaux B; Massias L; Chauveheid MP; Descamps D; Ghosn J; Peytavin G
    J Antimicrob Chemother; 2020 Sep; 75(9):2706-2707. PubMed ID: 32457980
    [No Abstract]   [Full Text] [Related]  

  • 35. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis.
    Aziz M; Fatima R; Lee-Smith W; Assaly R
    Crit Care; 2020 May; 24(1):255. PubMed ID: 32456658
    [No Abstract]   [Full Text] [Related]  

  • 36. Mild versus severe COVID-19: Laboratory markers.
    Velavan TP; Meyer CG
    Int J Infect Dis; 2020 Jun; 95():304-307. PubMed ID: 32344011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).
    Gutiérrez López de Ocáriz X; Castro Quismondo N; Vera Guerrero E; Rodríguez Rodríguez M; Ayala Díaz R; Martínez López J
    Int J Lab Hematol; 2020 Dec; 42(6):e280-e282. PubMed ID: 32851784
    [No Abstract]   [Full Text] [Related]  

  • 38. Preterm birth: Potential risk factor for greater COVID-19 severity?
    Debevec T; Burtscher J; Millet GP
    Respir Physiol Neurobiol; 2020 Sep; 280():103484. PubMed ID: 32599161
    [No Abstract]   [Full Text] [Related]  

  • 39. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.
    Zhang Y; Xiao M; Zhang S; Xia P; Cao W; Jiang W; Chen H; Ding X; Zhao H; Zhang H; Wang C; Zhao J; Sun X; Tian R; Wu W; Wu D; Ma J; Chen Y; Zhang D; Xie J; Yan X; Zhou X; Liu Z; Wang J; Du B; Qin Y; Gao P; Qin X; Xu Y; Zhang W; Li T; Zhang F; Zhao Y; Li Y; Zhang S
    N Engl J Med; 2020 Apr; 382(17):e38. PubMed ID: 32268022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
    Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
    Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.